CELZ
Creative Medical Technology Holdings, Inc. Common Stock
stockNASDAQ
creative medical technology holdings, inc., through its subsidiaries, engages in the stem cell research and developing applications to treat male sexual dysfunction and related issues. the company markets its erectile dysfunction (ed) treatment under the caverstem name to physicians for use with their patients suffering from ed. creative medical technology holdings, inc. was incorporated in 1998 and is based in phoenix, arizona. creative medical technology holdings, inc. is a subsidiary of creative medical health, inc.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.01 | 2026-09-28 | -5.97% | 4.805 |
| 1M | 1.11 | 2026-09-04 | -14.44% | 4.150 |
| 3M | 1.15 | 2026-07-06 | -17.42% | 1.342 |
| 6M | 2.14 | 2026-04-06 | -55.62% | 1.793 |
| 1Y | 3.38 | 2025-10-06 | -71.90% | 1.816 |
| 2Y | 3.00 | 2024-10-04 | -68.34% | — |
| 5Y | 0.14 | 2021-10-05 | +578.36% | -9.980 |
Creative Medical Technology Holdings, Inc. Common Stock (NASDAQ:CELZ) stock price today is $0.95, and today's volume is 89,494. CELZ is up 0.850% today. The 30 day average volume is 927,189. CELZ market cap is $7.21M with 7.59M shares outstanding.